Aciont

Non-invasive, controlled, and sustained release back-of-the-eye therapeutics for sight-threatening diseases such as: severe uveitis, diabetic macular...

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Aciont plus 5054 other startups.

Start Free 7 Day Trial Now

Learn More About Aciont

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups

More

Our Clients